BioHiTech Global, Inc. (NASDAQ:BHTG) has a beta value of 1.69 and has seen 86,289,107 shares traded in the recent trading session. The company, currently valued at $49.52 Million, closed the recent trade at $2.8498 per share which meant it gained $1.19 on the day or 72.12% during that session. The BHTG stock price is -54.4% off its 52-week high price of $4.4 and 64.56% above the 52-week low of $1.01. If we look at the company’s 10-day average daily trading volume, we find that it stood at 448.42 Million shares traded. The 3-month trading volume is 218.12 Million shares.

The consensus among analysts is that BioHiTech Global, Inc. (BHTG) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.13.

BioHiTech Global, Inc. (NASDAQ:BHTG) trade information

Sporting 75.76% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the BHTG stock price touched $4.4 or saw a rise of 28.79%. Year-to-date, BioHiTech Global, Inc. shares have moved 84.31%, while the 5-day performance has seen it change 110.28%. Over the past 30 days, the shares of BioHiTech Global, Inc. (NASDAQ:BHTG) have changed 198.4%. Short interest in the company has seen 34.27 Million shares shorted with days to cover at 0.16.

Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could jump -12.27% from current levels. The projected low price target is $2.5 while the price target rests at a high of $2.5. In that case, then, we find that the current price level is -12.27% off the targeted high while a plunge would see the stock lose -12.27% from current levels.

BioHiTech Global, Inc. (BHTG) estimates and forecasts

Figures show that BioHiTech Global, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +4.43% over the past 6 months, with this year growth rate of NA%, compared to NA% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 7.1% and 53.3% for the next quarter. Revenue growth from the last financial year stood is estimated to be +74.2%.

2 analysts offering their estimates for the company have set an average revenue estimate of $1.18 Million for the current quarter. 2 have an estimated revenue figure of $1.44 Million for the next quarter concluding in June 01, 2020. Year-ago sales stood $740Million for this quarter, and analysts expect sales will grow by 59.5% for the current quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +49.9% while over the next 5 years, the company’s earnings are expected to increase by 0%.

BioHiTech Global, Inc. (NASDAQ:BHTG)’s Major holders

Insiders own 40% of the company shares, while shares held by institutions stand at 6.72% with a share float percentage of 11.19%. Investors are also buoyed by the number of investors in a company, with BioHiTech Global, Inc. having a total of 20 institutions that hold shares in the company. The top two institutional holders are Bard Associates Inc. with over 668.24 Thousand shares worth more than $841.98 Thousand. As of March 30, 2020, Bard Associates Inc. held 4.51% of shares outstanding.

The other major institutional holder is Raymond James Financial Services Advisors, Inc., with the holding of over 118.69 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $149.54 Thousand and represent 0.8% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Gabelli ESG Fund. As of March 30, 2020, the former fund manager holds about 0.34% shares in the company for having 50469 shares of worth $63.59 Thousand while later fund manager owns 25Thousand shares of worth $31.5 Thousand as of March 30, 2020, which makes it owner of about 0.17% of company’s outstanding stock.